论文部分内容阅读
云南白药集团股份有限公司,是在云南白药实业股份有限公司基础上发展起来,并于1996年10月31日更名而来的。云南白药集团股份有限公司拥有资产2.6亿元,年销售收入上亿元,是国家二级企业,国家大二型企业,中国中成药行业五十强之一,是云南第一家A股股票上市公司,并获得企业经营进出口权。公司初具现代化生产规模,硬件基本满足GMP要求。产品畅销国内市场及港澳地区和东南亚国家,并进入美国和日本市场。具有近百年历史的云丰牌云南白药多次荣获国家质量金奖,被卫生部列为国家20年保护期的一级中药保护品种,并获
Yunnan Baiyao Group Co., Ltd. was developed based on Yunnan Baiyao Industrial Co., Ltd. and was renamed on October 31, 1996. Yunnan Baiyao Group Co., Ltd. has an asset of 260 million yuan and an annual sales income of 100 million yuan. It is a national secondary enterprise, a national second-tier enterprise, and one of the top 50 Chinese proprietary Chinese medicine companies. It is the first A-share listed company in Yunnan. Companies, and access to import and export business management rights. The company has a modern production scale and the hardware basically meets the GMP requirements. Products sell well in the domestic market and Hong Kong, Macao and Southeast Asian countries, and enter the United States and Japan market. Yunfeng Yunnanbaiyao, which has a history of nearly one hundred years, has won the National Quality Gold Medal for many times and was listed by the Ministry of Health as a Class I Chinese herbal protection product for 20 years of protection.